

Kymera Therapeutics shares surged after completing KT-621 Phase 2b enrollment early, accelerating data timing and Phase 3 plans.
You can purchase shares of ALPS Medical Breakthroughs ETF (ARCA:SBIO) through any online brokerage.
There are no as such competitors for ALPS Medical Breakthroughs ETF.
There is no analysis for ALPS Medical Breakthroughs ETF to provide a consensus price target.
The stock price for ALPS Medical Breakthroughs ETF (ARCA: SBIO) is $53.66 last updated November 2, 2026 at 12:13 PM EST.
There are no upcoming dividends for ALPS Medical Breakthroughs ETF.
ALPS Medical Breakthroughs ETF does not have any upcoming earnings scheduled.
There is no upcoming split for ALPS Medical Breakthroughs ETF.
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The...